The Michael J. Fox Foundation for Parkinson's Research (MJFF) has announced second-quarter 2012 participants in its Partnering Program. The Partnering Program proactively showcases promising research results from the MJFF portfolio — targeting funders who may wish to invest in their continued development.
"The challenges of translating basic discoveries into new therapies are incredibly complex,” said Michael J. Fox. “To conquer them, we all need to push ourselves further than we ever have before. Creating a win-win for companies and for patients requires rethinking how we deploy resources creatively and strategically in ways that benefit everyone."
The Partnering Program is designed to help speed therapeutic breakthroughs for Parkinson's disease (PD) by connecting industry leaders with projects ripe for investment. Non-confidential overviews of select MJFF-funded projects are shared with industry contacts and more broadly via MJFF’s Web site on a quarterly basis.
Learn more about the second-quarter participants here.